Role of the lectin-like domain of thrombomodulin in septic cardiomyopathy

• Published in: Life sciences (1973) 2022-10, Vol.306, p.120830-120830, Article 120830
• Main Authors: Voelker, Maria Theresa, Hechaichi, Nadine, Ndongson-Dongmo, Bernadin, Lemm, Jana, Heller, Regine, Bauer, Reinhardt, Conway, Edward M., Theilmeier, Gregor, Stehr, Sebastian N.
• Format: Article
• Language: English
• Subjects: Cardiomyocytes; Lectin like domain; LLD; Septic cardiomyopathy; Thrombomodulin
• ISSN: 0024-3205; 1879-0631
• DOI: 10.1016/j.lfs.2022.120830

Septic cardiomyopathy is a severe complication of sepsis and septic shock. This study aimed to evaluate the role of thrombomodulin and its lectin-like domain (LLD-TM) in the development of septic cardiomyopathy and the link between LLD-TM, HMGB-1, and toll-like receptors 2/4 (TLR 2/4) to intracellular mechanisms resulting in reduced cardiac function. Sepsis was induced using a polymicrobial peritoneal infection model in wildtype and mice lacking the lectin-like domain of thrombomodulin (TMLeD/LeD), and severity of disease and cardiac function was compared. Cell cultures of cardiomyocytes were prepared from hearts harvested from wildtype and TMLeD/LeD mice. Cultures of neonatal cardiomyocytes were transfected with complete human thrombomodulin or human thrombomodulin deficient of LLD-TM and when TLR-2 and/or TLR-4 were blocked. All cultures were challenged with inflammatory stimuli. Lack of the LLD-TM results in a significant increase in severity of disease, decreased survival and impaired cardiac function in septic mice. In vivo and in vitro analyses of cardiomyocytes displayed high levels of inflammatory cytokines causing cardio-depression. In vitro results showed a strong correlation between elevated HMGB-1 levels and elevated troponin-1 levels. No connection was found between HMGB-1 and TLR-2 and/or -4 signalling pathways. Phospholamban mediated dysregulation of calcium homeostasis resulted in a general impairment after sepsis induction, but showed no connection to LLD-TM. Lack of LLD-TM results in an increase in general severity of disease, decreased survival and impaired cardiac function in sepsis. TLR-2 and TLR 4 do not participate as mediating factors in the development of septic cardiomyopathy.